Investor Type | Firm |
Industries | BioTech • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Life Science • Oncology |
Stages | Early |
Investing | United States |
Investment Range | $500,000 - $500,000 |
The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) is a venture capital firm based in Harrisburg, Pennsylvania, dedicated to advancing healthcare by investing in early-stage life sciences technologies. With a bold mission to strengthen Pennsylvania's vibrant life sciences ecosystem and improve healthcare outcomes globally, they provide early-stage capital and operational expertise to innovative companies, fostering growth and job creation. As an evergreen venture fund, LSGPA offers a lifeline for companies navigating from pre-seed to Series B funding. They focus on Pennsylvania companies engaged in drug discovery, diagnostics, medical devices, and IT-driven solutions to major healthcare problems, usually investing between $250,000 to $500,000. They seek to bridge critical funding gaps and bring more than just financial investment, including access to a curated network of business and scientific advice. Their portfolio reflects their commitment, with $37 million invested in 72 companies and projects, which has leveraged $736 million in follow-on funding and led to 152 products being marketed or in development, as well as creating and retaining 8,500 direct and indirect jobs. LSGPA values its partnerships with entrepreneurs and scientists, emphasizing the importance of success beyond monetary gains. Their team combines experienced scientists and innovative business minds, delivering a unique understanding of the life sciences sector and related challenges.